A cyclin D2-Rb pathway regulates cardiac myocyte size and RNA polymerase III after biomechanical stress in adult myocardium

Circulation Research

Volumn 102, Issue 10, 2008, Pages 1222-1229

  Angelis, Ekaterini ^a   Garcia, Alejandro ^a   Chan, Shing S ^a   Schenke Layland, Katja ^a   Ren, Shuxen ^b   Goodfellow, Sarah J ^c   Jordan, Maria C ^b   Roos, Kenneth P ^b   White, Robert J ^a,c   MacLellan, W Robb ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Animal models of human disease; Cell signaling signal transduction; Genetically altered mice; Hypertrophy

Indexed keywords

BUTYRATE RESPONSE FACTOR 1; CYCLIN D2; DNA DIRECTED RNA POLYMERASE III; RETINOBLASTOMA PROTEIN; TATA BINDING PROTEIN; TRANSFER RNA; CCND2 PROTEIN, MOUSE; CYCLINE; E2F1 PROTEIN, MOUSE; E2F3 PROTEIN, MOUSE; E2F4 PROTEIN, MOUSE; E2F5 PROTEIN, MOUSE; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F3; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR E2F5;

ANIMAL CELL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; ATTENUATION; CELL SIZE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISSOCIATION; HEART MUSCLE; HEART MUSCLE CELL; HYPERTROPHY; IN VITRO STUDY; MECHANICAL STRESS; MITOSIS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WILD TYPE; AGE; ANIMAL; CARDIOMEGALY; CELL CULTURE; CYTOLOGY; DISEASE MODEL; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

AGE FACTORS; ANIMALS; CARDIOMEGALY; CELL SIZE; CELLS, CULTURED; CYCLINS; DISEASE MODELS, ANIMAL; E2F1 TRANSCRIPTION FACTOR; E2F3 TRANSCRIPTION FACTOR; E2F4 TRANSCRIPTION FACTOR; E2F5 TRANSCRIPTION FACTOR; MICE; MICE, MUTANT STRAINS; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHORYLATION; RATS; RETINOBLASTOMA PROTEIN; RNA POLYMERASE III; SIGNAL TRANSDUCTION; STRESS, MECHANICAL;

EID: 45149128576     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.107.163550     Document Type: Article

References (40)

1. Neufeld TP, Edgar BA. Connections between growth and the cell cycle. Curr Opin Cell Biol. 1998;10:784-790.
2. McGill CJ, Brooks G. Cell cycle control mechanisms and their role in cardiac growth. Cardiovasc Res. 1995;30:557-569.
3. Starksen NF, Simpson PC, Bishopric N, Coughlin SR, Lee WM, Escobedo JA, Williams LT. Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression. Proc Natl Acad Sci USA. 1986; 83:8348-8350.
4. Li JM, Poolman RA, Brooks G. Role of G1 phase cyclins and cyclin-dependent kinases during cardiomyocyte hypertrophic growth in rats. Am J Physiol. 1998;275:H814-H822.
5. Nozato T, Ito H, Tamamori M, Adachi S, Abe S, Marumo F, Hiroe M. G1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II Jpn Cire J. 2000;64:595-601.
6. Tamamori-Adachi M, Ito H, Nobori K, Hayashida K, Kawauchi J, Adachi S, Ikeda MA, Kitajima S. Expression of cyclin D1 and CDK4 causes hypertrophic growth of cardiomyocytes in culture: a possible implication for cardiac hypertrophy. Biochem Biophys Res Commun. 2002;296: 274-280.
7. Busk PK, Bartkova J, Strom CC, Wulf-Andersen L, Hinrichsen R, Christoffersen TE, Latella L, Bartek J, Haunso S, Sheikh SP. Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro. Cardiovasc Res. 2002;56:64-75.
8. Tamamori M, Ito H, Hiroe M, Terada Y, Marumo F, Ikeda MA. Essential roles for Gl cyclin-dependent kinase activity in development of cardiomyocyte hypertrophy. Am J Physiol. 1998;275:H2036-H2040.
9. Nozato T, Ito H, Watanabe M, Ono Y, Adachi S, Tanaka H, Hiroe M, Sunamori M, Marum F. Overexpression of cdk inhibitor pl6INK4a by adenovirus vector inhibits cardiac hypertrophy in vitro and in vivo: a novel strategy for the gene therapy of cardiac hypertrophy. J Mol Cell Cardiol. 2001;33:1493-1504.
10. Zhong W, Mao S, Tobis S, Angelis E, Jordan MC, Roos KP, Fishbein MC, de Alboran IM, MacLellan WR. Hypertrophie growth in cardiac myocytes is mediated by Myc through a cyclin D2-dependent pathway. EMBO J. 2006;25:3869-3879.
11. Sadoshima J, Aoki H, Izumo S. Angiotensin II and serum differentially regulate expression of cyclins, activity of cyclin-dependent kinases, and phosphorylation of retinoblastoma gene product in neonatal cardiac myocytes. Circ Res. 1997;80:228-241.
12. Kato JY, Matsuoka M, Strom DK, Sherr CJ. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol Cell Biol. 1994;14:2713-2721.
13. Herzinger T, Reed SI. Cyclin D3 is rate-limiting for the G1/S phase transition in fibroblasts. J Biol Chem. 1998;273:14958-14961.
14. Lundberg AS, Weinberg RA. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol. 1998;18:753-761.
15. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998;12:2245-2262.
16. Saavedra HI, Wu L, de Bruin A, Timmers C, Rosol TJ, Weinstein M, Robinson ML, Leone G. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Differ. 2002; 13:215-225.
17. White RJ, Trouche D, Martin K, Jackson SP, Kouzarides T. Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature. 1996;382:88-90.
18. Simone C, Bagella L, Bellan C, Giordano A. Physical interaction between pRb and cdk9/cyclinT2 complex. Oncogene. 2002;21:4158-4165.
19. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ, Weinberg RA. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature. 1996;384: 470-474.
20. MacLellan WR, Garcia A, Oh H, Frenkel P, Jordan MC, Roos KP, Schneider MD. Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol Cell Biol. 2005;25:2486-2497.
21. Xiao G, Mao S, Baumgarten G, Serrano J, Jordan MC, Roos KP, Fishbein MC, MacLellan WR. Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis. Circ Res. 2001;89:1122-1129.
22. Hu SX, Ji W, Zhou Y, Logothetis C, Xu HJ. Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression. Cancer Res. 1997;57:3339-3343.
23. Angelis E, Tse MY, Pang SC. Interactions between atrial natriuretic peptide and the renin-angiotensin system during salt-sensitivity exhibited by the proANP gene-disrupted mouse. Mol Cell Biochem. 2005;276: 121-131.
24. Hlaing M, Spitz P, Padmanabhan K, Cabezas B, Barker CS, Bernstein HS. E2F-1 regulates the expression of a subset of target genes during skeletal myoblast hypertrophy. J Biol Chem. 2004;279:43625-43633.
25. Goodfellow SJ, Innes F, Derblay LE, MacLellan WR, Scott PH, White RJ. Regulation of RNA polymerase III transcription during hypertrophic growth. EMBO J. 2006;25:1522-1533.
26. Winter AG, Sourvinos G, Allison SJ, Tosh K, Scott PH, Spandidos DA, White RJ. RNA polymerase III transcription factor TFIIIC2 is overex-pressed in ovarian tumors. Proc Natl Acad Sci USA. 2000;97: 12619-12624.
27. Crighton D, Woiwode A, Zhang C, Mandavia N, Morton JP, Warnock LJ, Milner J, White RJ, Johnson DL. p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB. EMBO J. 2003;22:2810-2820.
28. MacLellan WR, Xiao G, Abdellatif M, Schneider MD. A novel Rb- and p300-binding protein inhibits transactivation by MyoD. Mol Cell Biol. 2000;20:8903-8915.
29. Vara D, Bicknell KA, Coxon CH, Brooks G. Inhibition of E2F abrogates the development of cardiac myocyte hypertrophy. J Biol Chem. 2003; 278:21388-21394.
30. Cutilletta AF. Muscle and nonmuscle cell RNA polymerase activities in early myocardial hypertrophy. Am J Physiol. 1981;240:H901-H907.
31. Larminie CG, Cairns CA, Mital R, Martin K, Kouzarides T, Jackson SP, White RJ. Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein. EMBO J. 1997;16:2061-2071.
32. Soonpaa MH, Koh GY, Pajak L, Jing S, Wang H, Franklin MT, Kim KK, Field LJ. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest. 1997;99:2644-2654.
33. Pasumarthi KB, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res. 2005;96:110-118.
34. Busk PK, Hinrichsen R, Bartkova J, Hansen AH, Christoffersen TE, Bartek J, Haunso S. Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy. Exp Cell Res. 2005;304:149-161.
35. Datar SA, Jacobs HW, de la Cruz AF, Lehner CF, Edgar BA. The Drosophila cyclin D-Cdk4 complex promotes cellular growth. EMBO J. 2000;19:4543-4554.
36. Soonpaa MH, Field LJ. Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am J Physiol. 1994;266: H1439-H1445.
37. Kirshenbaum LA, Schneider MD. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains. J Biol Chem. 1995;270:7791-7794.
38. Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson RT, Akashi K, Sicinski P. Mouse development and cell proliferation in the absence of D-cyclins. Cell. 2004;118:477-491.
39. Sutcliffe JE, Brown TR, Allison SJ, Scott PH, White RJ. Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription. Mol Cell Biol. 2000;20:9192-9202.
40. Larminie CG, Alzuherri HM, Cairns CA, McLees A, White RJ. Transcription by RNA polymerases I and III: a potential link between cell growth, protein synthesis and the retinoblastoma protein. J Mol Med. 1998;76:94-103.